Veracyte raises $30M in follow-on

Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) raised $30 million through the sale of 5 million shares at $6 in a follow-on underwritten by Leerink and BTIG. The price is a 16% discount to Veracyte's $7.13 closing price on Tuesday, when the company announced the offering after market hours.

Last month, the company launched its Envisia Genomic Classifier, a diagnostic tool for idiopathic pulmonary fibrosis (IPF)...